Novo Nordisk
248,75 krVariación respecto al cierre anterior: −0,50 %Variación absoluta: −1,25 kr
En resumen
- Crecimiento de los ingresos
- +6,43 %
- 2025 frente a 2024
- Crecimiento del beneficio neto
- +1,43 %
- 2025 frente a 2024
- Margen neto
- 33,1 %
- 2024: 34,8 %
Datos financieros
Importes en millones de DKK; valores por acción en DKK; acciones en millones.
| Partida | T2 2026 | T1 2026 | T4 2025 | T3 2025 | T2 2025 | T1 2025 | T4 2024 | T3 2024 | T2 2024 | T1 2024 | T4 2023 | T3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | 78.488 | 96.823 | 79.144 | 74.976 | 76.857 | 78.087 | 85.683 | 71.311 | 68.060 | 65.349 | 65.863 | 58.731 |
| Coste de ventas | 17.100 | 13.598 | 14.170 | 14.471 | 12.846 | 12.890 | 12.062 | 11.308 | 10.274 | 9.916 | 9.568 | 9.713 |
| Beneficio bruto | 61.388 | 83.225 | 64.974 | 60.505 | 64.011 | 65.197 | 73.621 | 60.003 | 57.786 | 55.433 | 56.295 | 49.018 |
| Gastos generales, de venta y administración | 16.306 | 13.217 | 17.143 | 15.761 | 18.849 | 16.112 | 20.272 | 16.592 | 16.091 | 14.413 | 18.622 | 14.075 |
| Investigación y desarrollo | 11.459 | 10.284 | 12.671 | 11.490 | 11.690 | 10.308 | 5.812 | 9.488 | 10.466 | 8.606 | 9.092 | 8.128 |
| Resultado operativo | 33.389 | 59.618 | 35.241 | 33.254 | 33.449 | 38.791 | 47.299 | 33.822 | 31.634 | 31.846 | 28.890 | 26.913 |
| EBIT | 33.389 | 59.618 | 35.241 | 33.254 | 33.449 | 38.791 | 47.299 | 33.822 | 31.634 | 31.846 | 28.890 | 26.913 |
| EBITDA | 36.994 | 63.131 | 36.655 | 36.491 | 37.193 | 42.550 | 47.875 | 35.842 | 33.671 | 34.003 | 30.346 | 29.438 |
| Gastos financieros | 1.500 | 3.499 | 4.966 | — | 4.958 | 5.183 | 400 | — | 1.562 | 1.998 | 1.630 | 2.168 |
| Beneficio antes de impuestos | 26.875 | 62.172 | 34.185 | 25.517 | 33.805 | 37.033 | 35.557 | 34.384 | 25.332 | 31.918 | 27.620 | 28.063 |
| Impuestos | 5.886 | 13.615 | 7.294 | 5.511 | 7.302 | 7.999 | 7.327 | 7.083 | 5.282 | 6.511 | 5.657 | 5.585 |
| Beneficio neto | 20.989 | 48.557 | 26.891 | 20.006 | 26.503 | 29.034 | 28.230 | 27.301 | 20.050 | 25.407 | 21.963 | 22.478 |
| Beneficio neto para accionistas ordinarios | 20.989 | 48.557 | 26.891 | 20.006 | 26.503 | 29.034 | 28.230 | 27.301 | 20.050 | 25.407 | 21.963 | 22.478 |
| BPA básico | 4,74 | 10,93 | 6,05 | 4,50 | 5,96 | 6,54 | 6,35 | 6,13 | 4,50 | 5,70 | 4,92 | 5,02 |
| BPA diluido | 4,73 | 10,91 | 6,04 | 4,50 | 5,96 | 6,53 | 6,34 | 6,12 | 4,49 | 5,68 | 4,91 | 5,00 |
| Acciones medias (básicas) | 4.428 | 4.443 | 4.444 | 4.444 | 4.447 | 4.439 | 4.446 | 4.452 | 4.458 | 4.460 | 4.465 | 4.477 |
| Acciones medias (diluidas) | 4.436 | 4.449 | 4.449 | 4.447 | 4.447 | 4.446 | 4.456 | 4.461 | 4.465 | 4.471 | 4.477 | 4.489 |
| Dividendo por acción | 3,75 | — | 7,95 | — | 3,75 | — | 7,90 | — | 3,50 | — | 6,40 | — |